Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors

Bone Marrow Transplantation

Volumn 19, Issue 3, 1997, Pages 241-248

  Takenaka, K ^a   Gondo, H ^a   Tanimoto, K ^a   Nagafuji, K ^a   Fujisaki, T ^a   Mizuno, S ^a   Miyamoto, T ^a   Okamura, T ^a   Hayashi, S ^b   Eto, T ^b   Osaki, K ^b   Yamasaki, K ^c   Shibuya, T ^c   Harada, N ^c   Teshima, T ^d   Matsuishi, E ^e   Minematsu, T ^f   Minamishima, Y ^f   Harada, M ^g   Niho, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARASANSHIN HOSPITAL   (Japan)

^c HAMANOMACHI HOSPITAL   (Japan)

^d KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^e Koseikan Hospital   (Japan)

^f UNIVERSITY OF MIYAZAKI   (Japan)

^g OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

CMV antigenemia; CMV associated disease; Unrelated donor BMT

Indexed keywords

GANCICLOVIR; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CYTOMEGALIC INCLUSION BODY DISEASE; DONOR; EARLY DIAGNOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; INCIDENCE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIBLING;

EID: 0031054161     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700637     Document Type: Article

References (41)

1. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153; 478-488.
2. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of 10 years' experience. Rev Infect Dis 1982; 4: 1119-1132.
3. Frank I, Friedman HM. Progress in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1988; 109: 769-771.
4. Emanuel D, Cunningham I, Jules-Elysee K et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777-782.
5. Reed EC, Bowden RA, Dandliker PS et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988; 109: 783-788.
6. Schmidt GM, Kovacs A, Zaia JA et al. Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 1988; 46: 905-907.
7. Forman SJ, Zaia JA. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994; 83: 2392-2398.
8. Miller W, Flynn P, McCullough J et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 1986; 67: 1162-1167.
9. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
10. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
11. Downie TR, Hows JM, Gore SM et al. A survey of use of unrelated volunteer donor bone marrow transplantation at 46 centres worldwide, 1989-93. International Marrow Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplant 1995; 15: 499-503.
12. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. Ann Intern Med 1993; 119: 207-214.
13. Phillips GL, Nevill TJ, Spinelli JJ et al. Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation. Bone Marrow Transplant 1995; 15: 213-219.
14. van der Bij W, van Son WJ, van der Berg AP et al. Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. Transplant Proc 1989; 21: 2061-2064.
15. Boeckh M, Bowden RA, Goodrich JM et al. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 1992; 80: 1358-1364.
16. Gondo H, Minematsu T, Harada M et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994; 86: 130-137.
17. Koskinen PK, Nieminen MS, Mattila SP et al. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation 1993; 55: 547-551.
18. de Thé TH, van der Ploeg M, van den Berg AP et al. Direct detection of cytomegalovirus in peripheral blood leukocytes -a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193-198.
19. van der Bij W, Torensma R, van Son WJ et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988; 25: 179-188.
20. van der Bij W, Schirm J, Torensma R et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J Clin Microbiol 1988; 26: 2531-2535.
21. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
22. Gondo H, Harada M, Taniguchi S et al. Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease. Bone Marrow Transplant 1993; 12: 437-441.
23. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation (second of two parts.) New Engl J Med 1975; 292: 895-902.
24. Eizuru Y, Minematsu T, Minamishima Y et al. Rapid diagnosis of cytomegalovirus infections by direct immunoperoxidase staining with human monoclonal antibody against an immediate-early antigen. Microbiol lmmunol 1991; 35: 1015-1022.
25. Minematsu T, Hosoda K, Minamishima Y. Evaluation of direct immunoperoxidase technique using F(ab′)2 fractions of anti-cytomegalovirus human monoclonal antibody for enumeration of cytomegalovirus antigen-positive leukocytes. Kansenshogaku Zasshi 1994; 68: 1278-1284 (in Japanese).
26. van de Berg AP, van der Bij W, van Son WJ et al. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consecutive patients. Transplantation 1989; 48: 991-995.
27. de Thé TH, van der Bij W, van den Berg AP et al. Cytomegalovirus antigenemia. Rev Inf Dis 1990; 12 (Suppl. 7): S737-S744.
28. Wingard JR, Chen DY, Burns WH et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic hone marrow transplantation. Blood 1988; 71: 1432-1437.
29. Appelbaum FR, Meyers JD, Fefer A et al. Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 1982; 33: 265-268.
30. Cheung K-S, Lang DJ. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J Infect Dis 1977; 135: 841-845.
31. Braun RW, Reiser HC. Replication of human cytomegalovirus in human periperal blood T cells. J Virol 1986; 60: 29-36.
32. Klein HG. Wolf in wolf's clothing: is it time to raise the bounty on the passenger leukocyte? Blood 1992; 80: 1865-1868.
33. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors. Bone Marrow Transplant 1991; 8: 217-223.
34. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
35. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993; 81: 1923-1932.
36. de Thé TH, van den Berg AP, van Son WJ et al. Monitoring for cytomegalovirus after organ transplantation: a clinical perspective. Transplant Proc 1993; 25 (Suppl. 4) 5-9.
37. Revello MG, Percivalle E, Zavattoni M et al. Detection of human cytomegalovirus immediate-early antigen in leukocytes as a marker of viremia in immunocompromised patients. J Med Virol 1989; 29: 88-93.
38. Beatty PG Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. New Engl J Med 1985; 313: 765-771.
39. Koehler M, St George K, Rinaldo C Jr. The evaluation of results of CMV antigenaemia assays in bone marrow transplant recipients. Br J Haematol 1995; 89: 427 (letter).
40. Morishima Y, Morishita Y, Tanimoto M et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity. Blood 1989; 74: 2252-2256.
41. Morishima Y, Kodera Y, Hirabayahsi N et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15: 235-239.